Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Vaxcyte, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 78 | 1 | 87 | +10 |
| Shares | 43.2M | 4.25M | 44.7M | +5.78M (+14.8%) |
| Value | $1.10B | $107.9M | $1.06B | +$75.5M (+7.6%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Vaxcyte, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TPG GP A, LLC | 4,207,575 | $100.1M | 1.00% |
| Kynam Capital Management, LP | 211,483 | $5.03M | 2.69% |
| Woodline Partners LP | 97,396 | $2.32M | 0.03% |
| Gyon Technologies Capital Management, LP | 31,342 | $746.0K | 0.14% |
| EcoR1 Capital, LLC | 20,800 | $495.0K | 0.02% |
| Baker Avenue Asset Management, LP | 13,780 | $328.0K | 0.02% |
| Renaissance Technologies LLC | 13,000 | $309.0K | 0.00% |
| Ergoteles LLC | 12,811 | $305.0K | 0.01% |
| Prudential Financial Inc | 9,920 | $236.0K | 0.00% |
| Amundi | 5,795 | $115.0K | 0.00% |
| Advisor Group Holdings, Inc. | 2,000 | $53.0K | 0.00% |
| Ensign Peak Advisors, Inc | 1,420 | $34.0K | 0.00% |
| Nisa Investment Advisors, LLC | 1,530 | $29.0K | 0.00% |
| CWM, LLC | 22 | $1.00K | 0.00% |
| Signaturefd, LLC | 9 | $0 | 0.00% |
| Covestor Ltd | 17 | $0 | 0.00% |
Sold out (6)
Institutions that held Vaxcyte, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Sabby Management, LLC | 66,483 | $1.69M |
| Affinity Asset Advisors, LLC | 50,000 | $1.27M |
| ExodusPoint Capital Management, LP | 14,300 | $363.0K |
| Principal Financial Group Inc | 10,121 | $257.0K |
| Penserra Capital Management LLC | 1,195 | $30.0K |
| Parallel Advisors, LLC | 28 | $1.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Vaxcyte, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. | 4,254,390 | $107.9M |